We asked several healthcare executives what they are hearing their colleagues talk about the most. Here’s what they said.
A first-of-its kind study examined the association between using medication to treat OUD and mortality in patients who had a nonfatal opioid overdose.
Have two minutes? Listen to this quick podcast for critical takeaways from three of our top articles.
New Cardinal Health Specialty Solutions research shares inside information about oncologists’ views about targeted therapies.
The law opens up new options for terminally ill patients. But how will it impact managed care organizations?
FDA’s plan to evaluate gene therapies’ impact on surrogate end points is amping up concerns among payers. Here’s why
Cambia Health Solutions’ Laurent Rotival, MS, reveals what can happen when Amazon’s principles muscle in on the traditional healthcare model.
Trust in the healthcare sector is dropping, a warning sign to executives. Here’s four ways how to reclaim it.
From the frontlines of healthcare, Sarah Krevans, MBA, MPH, Sutter Health, offers AHIP attendees her ideas on healthcare transformation, future outlook, and consumer empowerment.
Trepidation by providers to take on more risk is threatening the road to value-based care.